• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    MEDIROM Healthcare Technologies Inc. Announces November 2024 Key Performance Indicators (KPIs)

    12/23/24 10:08:04 AM ET
    $MRM
    Other Consumer Services
    Consumer Discretionary
    Get the next $MRM alert in real time by email

    TOKYO, Dec. 23, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a holistic healthcare company based in Japan (the "Company"), today announced its major Key Performance Indicators, or KPIs, updated for the month of November 2024. Data is provided for all salons for which comparable financial and customer data is available and excludes certain salons where such information is not available.

    Salon Operation Business

    The following monthly KPIs provide insight into the business fundamentals and progress of the Company, updated for the month of November 2024:

    • Total customers served increased to 75,760 in November 2024 from 75,290 in the year-ago period.
    • Sales per customer increased to JPY 7,055 in November 2024 from JPY 7,045 in the year-ago period.
    • Repeat ratio, which indicates the percentage of repeat customers, was 77.5% in 2024, the same as 77.5% in the year-ago period.
    • Operation ratio was 44.6% in November 2024, up from 43.9% in the year-ago period.
     Number of Salons(*1)Number of Salons with Data(*2)Total Customers Served(*3)Sales per Customer(*4)Repeat Ratio(*5)Operation Ratio(*6)
    November-2331328975,290JPY 7,04577.5%43.9%
    December-2331429083,124JPY 7,27177.7%46.7%
    January-2431128774,533JPY 7,14776.8%44.7%
    February-2431128771,376JPY 7,09977.6%44.9%
    March-2431228877,854JPY 7,19077.9%45.7%
    April-2430828574,621JPY 7,14375.9%43.5%
    May-2430728480,512JPY 6,96474.8%44.9%
    June-2430828582,656JPY 7,06175.6%47.4%
    July-2430928681,580JPY 7,06075.0%46.6%
    August-2430728383,770JPY 7,14475.1%47.3%
    September-2430828482,401JPY 7,15875.8%48.0%
    October-2430728279,571JPY 6,92376.6%45.5%
    November-2430828375,760JPY 7,05577.5%44.6%
           

    (*1) Number of Salons: Includes the Company's directly-operated salons and franchisees' salons.

    (*2) Number of Salons with Data: The number of salons for which comparable financial and customer data is available.

    (*3) Total Customers Served: The number of customers served at salons for which comparable financial and customer data is available.

    (*4) Sales Per Customer: The ratio of total salon sales to number of treated customers at all salons for which comparable financial and customer data is available.

    (*5) Repeat Ratio: The ratio of repeat customer visits to total customer visits in the applicable month for all salons for which comparable financial and customer data is available.

    (*6) Operation Ratio: The ratio of therapists' in-service time to total therapists' working hours (including stand-by time) for the applicable month for all salons for which comparable financial and customer data is available.

    tbd

    tbd

    tbd

    tbd

    * Repeat ratios shown in the chart above do not include salons in public bath houses. In November 2024, the repeat ratios for all salons and salons in public bathhouses only were 77.5% and 56.9%, respectively.

    tbd

    *Since July 2021, the salon operation business has been managed by Wing Inc., which is a wholly-owned subsidiary of the Company.

    Health Tech Business (Lav®)

    The Company offers a government-specific health guidance program (the "Program") using Lav®, an on-demand training application developed by the Company. The Program is designed to be less burdensome for the users and is delivered through a completely remote support style using the web remote interview and chat function of Lav®. This approach helps to reduce the dropout rate of conventional specific health guidance programs.

    The Program provides support to medical professionals, such as public health nurses, dietitians, etc., that assist eligible individuals (age between 40 and 74) who are at risk of developing lifestyle-related diseases that can be caused by an unbalanced diet, lack of sleep, lack of exercise, smoking, stress, and other factors, by reviewing their lifestyle habits through specific health checkups that focus on metabolic syndrome. The implementation of specific health checkups and specific health guidance has become mandatory for medical insurers in Japan, including national health insurance and employee health insurance providers, since April 2008.

    The Ministry of Health, Labor and Welfare has set a nationwide target of at least 70% for specific medical checkup implementation rates and at least 45% for specific health guidance implementation rates. In fiscal year 2021, however, the medical checkup implementation rates and specific health guidance implementation rates were only 56.5% and 24.6%, respectively. As a result, the market for these services is expected to expand due to the government's effort to achieve the set target implementation rates. According to a survey by the Japan Health Guidance Association, the utilization of Information and Communication Technology (ICT) has been increasing, and the adoption rate has exceeded 50% due to the impact of COVID-19 in recent years.

    As of November 2024, the Company has entered into contracts with 95 corporate insurance associations, and the cumulative number of users of the Company's Lav® app has exceeded 8,000 people, bringing the total to 8,515 individuals.

     Number of New Contracts with Corporate Insurance Associations(*1)Number of New Users(*2)Cumulative Number of Contracts with Corporate Insurance Associations(*3)Cumulative Number of Users
    November-231256736,262
    December-231161746,423
    January-241174756,597
    February-241152766,749
    March-241203766,952
    April-243187797,139
    May-24299817,238
    June-242131837,369
    July-241166847,535
    August-243109877,644
    September-240221877,865
    October-246320938,185
    November-242330958,515
         

    (*1) Number of new contracts with corporate insurance associations entered into in the applicable month to implement specified health guidance program offered by the Company.

    (*2) Number of new users that started using specified health guidance offered by the Company in the applicable month.

    (*3) Cumulative number of contracts with corporate insurance associations excluding the number of terminated contracts.

    tbd

    Chart of KPI

    Forward-Looking Statements

    Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about the Company's possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as "may," "will," "should," "design," "target," "aim," "hope," "expect," "could," "intend," "plan," "anticipate," "estimate," "believe," "continue," "predict," "project," "potential," "goal," or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company's control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to the Company's operations, results of operations, growth strategy and liquidity. Some of the factors that could cause actual results to differ materially from those expressed or implied by the forward-looking statements in this press release include:

    • the Company's ability to achieve its development goals for its business and execute and evolve its growth strategies, priorities and initiatives;
    • the Company's ability to sell certain of its owned salons to investors, and receive management fees from such sold salons, on acceptable terms;
    • changes in Japanese and global economic conditions and financial markets, including their effects on the Company's expansion in Japan and certain overseas markets;
    • the Company's ability to achieve and sustain profitability in its Digital Preventative Healthcare Segment;
    • the fluctuation of foreign exchange rates, which affects the Company's expenses and liabilities payable in foreign currencies;
    • the Company's ability to hire and train a sufficient number of therapists and place them at salons in need of additional staffing;
    • changes in demographic, unemployment, economic, regulatory or weather conditions affecting the Tokyo region of Japan, where the Company's relaxation salon base is geographically concentrated;
    • the Company's ability to maintain and enhance the value of its brands and to enforce and maintain its trademarks and protect its other intellectual property;
    • the financial performance of the Company's franchisees and the Company's limited control with respect to their operations;
    • the Company's ability to raise additional capital on acceptable terms or at all;
    • the Company's level of indebtedness and potential restrictions on the Company under the Company's debt instruments;
    • changes in consumer preferences and the Company's competitive environment;
    • the Company's ability to respond to natural disasters, such as earthquakes and tsunamis, and to global pandemics, such as COVID-19; and
    • the regulatory environment in which the Company operates.

    More information on these risks and other potential factors that could affect the Company's business, reputation, results of operations, financial condition, and stock price is included in the Company's filings with the Securities and Exchange Commission (the "SEC"), including in the "Risk Factors" and "Operating and Financial Review and Prospects" sections of the Company's most recently filed periodic report on Form 20-F and subsequent filings, which are available on the SEC website at www.sec.gov. The Company assumes no obligation to update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ from those anticipated in these forward-looking statements, even if new information becomes available in the future.

    About MEDIROM Healthcare Technologies Inc.

    MEDIROM, a holistic healthcare company, operates 308 (as of November 30, 2024) relaxation salons across Japan, Re.Ra.Ku® being its leading brand, and provides healthcare services. In 2015, MEDIROM entered the health tech business and launched new healthcare programs using an on-demand training app called "Lav®", which is developed by the Company. MEDIROM also entered the device business in 2020 and has developed a smart tracker "MOTHER Bracelet®". In 2023, MEDIROM launched REMONY, a remote monitoring system for corporate clients, and has received orders from a broad range of industries, including nursing care, transportation, construction, and manufacturing, among others. MEDIROM hopes that its diverse health-related product and service offerings will help it collect and manage healthcare data from users and customers and enable it to become a leader in big data in the healthcare industry. For more information, visit https://medirom.co.jp/en.

    Contacts

    Investor Relations Team

    [email protected]

    Photos accompanying this announcement are available at:

    https://www.globenewswire.com/NewsRoom/AttachmentNg/044097ba-afae-4c7e-873a-d6c864729cce

    https://www.globenewswire.com/NewsRoom/AttachmentNg/095a807a-8dbc-43a6-9a11-0a2a1417d3db

    https://www.globenewswire.com/NewsRoom/AttachmentNg/a31937c9-e59c-4cff-9c46-0e75e4440dd2

    https://www.globenewswire.com/NewsRoom/AttachmentNg/f2fcdb5d-8393-46d1-9f3d-73d7a4e2ecb4

    https://www.globenewswire.com/NewsRoom/AttachmentNg/e6ed0bcb-54f5-419b-b54d-d3f0086f4bdc

    https://www.globenewswire.com/NewsRoom/AttachmentNg/ec917127-1447-4db9-bf54-c489f757898e

    https://www.globenewswire.com/NewsRoom/AttachmentNg/09ed0042-eb22-4eb2-b449-6ad4bb0b1298



    Primary Logo

    Get the next $MRM alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MRM

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $MRM
    Financials

    Live finance-specific insights

    See more
    • MEDIROM Rehab Solutions Inc. Acquires Rehabilitation Centers from Y's, Inc.

      TOKYO, Oct. 07, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) ("Medirom" or the "Company") is pleased to announce that it is capitalizing on its extensive experience operating wellness clinics and healthcare technology to expand into the rehabilitation industry. In doing so, MEDIROM established a wholly-owned subsidiary, MEDIROM Rehab Solutions Inc., which acquired all of the rehabilitation centers of Y's, Inc. Prior to the acquisition by MEDIROM Rehab Solutions Inc., Y's, Inc. owned and operated ten cerebral infarction rehabilitation centers in Tokyo and other major cities across Japan. Cerebral infarction rehabilitation is a comprehensive program designed to

      10/7/24 4:00:00 PM ET
      $MRM
      Other Consumer Services
      Consumer Discretionary
    • MEDIROM Healthcare Technologies Inc. Announces Financial Results for Fiscal Year 2023

      TOKYO, June 25, 2024 (GLOBE NEWSWIRE) --  MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) ("Medirom" or the "Company"), a holistic healthcare company based in Japan, announced it filed its Annual Report on Form 20-F for the year ended December 31, 2023 with the U.S. Securities and Exchange Commission ("SEC"), including consolidated financial statements prepared in accordance with U.S. generally accepted accounting principles ("GAAP"), on June 18, 2024. Kouji Eguchi, Chief Executive Officer of the Company, stated, "I am very pleased to announce that during a period of significant investment and development in our healthcare technology systems and products in FY 2023 and FY 2022, as wel

      6/25/24 9:37:44 AM ET
      $MRM
      Other Consumer Services
      Consumer Discretionary
    • MEDIROM Healthcare Technologies Inc. Announces Preliminary 2021 Financial Results

      NEW YORK, May 13, 2022 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a holistic healthcare company based in Japan (the "Company"), today announced its preliminary unaudited financial results for the fiscal year ended December 31, 2021, prepared in accordance with U.S. GAAP. Due to additional time required to complete its year-end reporting process, the Company determined that it was unable to file its Annual Report on Form 20-F for the fiscal year ended December 31, 2021, within the prescribed time period without unreasonable effort and expense. The Company filed a Notification of Late Filing on Form 12b-25 with the U.S. Securities and Exchange Commission o

      5/13/22 7:53:59 AM ET
      $MRM
      Other Consumer Services
      Consumer Discretionary

    $MRM
    Leadership Updates

    Live Leadership Updates

    See more
    • "NASDAQ JAPAN IR EVENT" to Be Held at Nasdaq MarketSite on June 20, 2024

      NEW YORK, May 20, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a holistic healthcare company based in Japan ("MEDIROM", the "Company"), today announced it will participate in a "NASDAQ JAPAN IR EVENT" to be held at Nasdaq MarketSite in Times Square on June 20, 2024. Five companies are currently expected to join this event (including one private company), and we will share information about the attractive nature of the Japanese market with a global audience. PurposeIn December 2020, the Company became the first Japanese company in 21 years to list on Nasdaq. Today, the number of Japanese companies listed on Nasdaq has increased to eight. While more and mor

      5/20/24 3:00:00 PM ET
      $MRM
      Other Consumer Services
      Consumer Discretionary

    $MRM
    SEC Filings

    See more
    • SEC Form 6-K filed by MEDIROM Healthcare Technologies Inc.

      6-K - Medirom Healthcare Technologies Inc. (0001819704) (Filer)

      5/20/25 8:00:20 AM ET
      $MRM
      Other Consumer Services
      Consumer Discretionary
    • SEC Form 6-K filed by MEDIROM Healthcare Technologies Inc.

      6-K - Medirom Healthcare Technologies Inc. (0001819704) (Filer)

      5/20/25 6:10:32 AM ET
      $MRM
      Other Consumer Services
      Consumer Discretionary
    • SEC Form 20-F filed by MEDIROM Healthcare Technologies Inc.

      20-F - Medirom Healthcare Technologies Inc. (0001819704) (Filer)

      4/29/25 4:15:44 PM ET
      $MRM
      Other Consumer Services
      Consumer Discretionary

    $MRM
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • MEDIROM Healthcare Technologies Inc. Announces 22% Rise in Revenue and 20% Improvement in Earnings for 2024; Webcast to Discuss Financial Results to be held on May 21st, 2025 at 8:30 AM ET

      TOKYO, May 20, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a holistic healthcare company based in Japan (the "Company" or "MEDIROM"), today announced that for the year ended December 31, 2024, the Company had total revenue of $52,736,000, a 22% increase over total revenue of $43,388,000 for the year ended December 31, 2023. (The Company reports its financial results in Japanese yen and figures presented in this press release in US dollars have been translated for convenience at the exchange rate of ¥ 157.37 = US$1.00. See "Convenience Translations to US Dollars" below for more information.) Net income for 2024 was $878,000, or $0.17 per basic share,

      5/20/25 8:56:16 AM ET
      $MRM
      Other Consumer Services
      Consumer Discretionary
    • MEDIROM Healthcare Technologies Inc. to Host Webcast on May 21, 2025 at 8:30 AM ET to Discuss 2024 Financial Results

      TOKYO, May 19, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a holistic healthcare company based in Japan (the "Company" or "MEDIROM") today announced that it will host a webcast to review the Company's financial results for the fiscal year ended December 31, 2024, on Wednesday, May 21, 2025 at 8:30 am Eastern Time. The Company will issue a press release discussing those results after the market close on Tuesday, May 20th, 2025. In addition, on April 29, 2025, the Company filed its most recent annual report on Form 20-F, which annual report covers the Company's financial results for the 2024 fiscal year and is available on the Securities and Exchange Comm

      5/19/25 8:44:53 AM ET
      $MRM
      Other Consumer Services
      Consumer Discretionary
    • MEDIROM Healthcare Technologies Inc. Announces New JPY350 Million (Approximately $2.4 Million*) Unsecured Loan Financing

      TOKYO, March 17, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a holistic healthcare company based in Japan (the "Company" or "MEDIROM"), today announced that it has obtained a new unsecured short-term bank loan in the amount of JPY350 million (approximately $2.4 million*). The Company has used JPY200 million of the loan funds for repayment of indebtedness of MEDIROM Mother Labs Inc., a subsidiary of the Company which is also a guarantor of the new loan, and the Company intends to use the remainder of the loan funds for general working capital, including Mother Bracelet development. The loan bears interest at a rate of 1.875% per year. "This new loan fina

      3/17/25 5:30:00 PM ET
      $MRM
      Other Consumer Services
      Consumer Discretionary

    $MRM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by MEDIROM Healthcare Technologies Inc.

      SC 13G - Medirom Healthcare Technologies Inc. (0001819704) (Subject)

      12/10/24 7:38:12 AM ET
      $MRM
      Other Consumer Services
      Consumer Discretionary
    • SEC Form SC 13D filed by MEDIROM Healthcare Technologies Inc.

      SC 13D - Medirom Healthcare Technologies Inc. (0001819704) (Subject)

      1/25/23 4:16:06 PM ET
      $MRM
      Other Consumer Services
      Consumer Discretionary
    • SEC Form SC 13D filed by MEDIROM Healthcare Technologies Inc.

      SC 13D - Medirom Healthcare Technologies Inc. (0001819704) (Subject)

      1/6/23 6:12:19 AM ET
      $MRM
      Other Consumer Services
      Consumer Discretionary